Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) SHH

94.42

-1.87(-1.94%)

Updated at February 13 03:00PM

Currency In CNY

Valuation

Market Cap16.52B
Enterprise Value15.39B
P/E Ratio-187.44
PEG Ratio-25.77
Price/Sales Ratio33.67
Price/Book Ratio21.75
Enterprise/Revenue32.43
Enterprise/EBITDA-136.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.21

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.11

Income Statement

Revenue532.95M
Revenue/Share2.8
Gross Profit495.23M
EBITDA-174.1M
Net Income-137.83M
Diluted EPS-0.52

Balance Sheet

Total Cash2.09B
Total Cash/Share7.88
Total Debt1.15B
Total Debt/Equity1
Current Ratio1.85
Book Value Per Share4.34

Price History

52-Week Change27.08
52-Week High134.17
52-Week Low67.13
Moving Average 50 Days95.23
Moving Average 200 Days105.38

Statistics

Average Volume2.74M
Shares Outstanding264.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.14
Last Split FactorN/A
Last Split DateN/A